Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
about
Biosimilars for the Treatment of Cancer: A Systematic Review of Published EvidenceSystematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases.Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis.Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassaysTNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.The use of biosimilar medicines in oncology - position statement of the Brazilian Society of Clinical Oncology (SBOC).A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis.Worldwide perspective of biosimilars for psoriasis.A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo.
P2860
Q36247037-BFAC3A25-725D-4691-B8EE-D248D93F76DCQ39152159-9C888BC0-5B7B-4969-9307-485608E11C89Q40081220-2B760D13-D7EC-440A-94B4-26F056D58D81Q41078498-94CC41F1-3A2C-40BB-88C5-D992BB01CC99Q47347321-053F3BB6-53D9-4769-BED3-0CBB2C6DE146Q48267381-A2F004B0-B13F-4F77-B797-AC8FE15B94ABQ48502863-C1E60D3E-3B9C-4989-AF65-97A97379D268Q49490534-961FF489-433E-4F56-8F8B-BEE616211077Q50125468-F5EC403E-3DF0-4E49-A082-CC5F7DD9DD92Q55516794-668F5025-8A8F-4973-B249-02379B192C7D
P2860
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Biosimilars for the Treatment ...... c Review of Published Evidence
@ast
Biosimilars for the Treatment ...... c Review of Published Evidence
@en
Biosimilars for the Treatment ...... c Review of Published Evidence
@nl
type
label
Biosimilars for the Treatment ...... c Review of Published Evidence
@ast
Biosimilars for the Treatment ...... c Review of Published Evidence
@en
Biosimilars for the Treatment ...... c Review of Published Evidence
@nl
prefLabel
Biosimilars for the Treatment ...... c Review of Published Evidence
@ast
Biosimilars for the Treatment ...... c Review of Published Evidence
@en
Biosimilars for the Treatment ...... c Review of Published Evidence
@nl
P2093
P2860
P1433
P1476
Biosimilars for the Treatment ...... c Review of Published Evidence
@en
P2093
Danielle Petersel
Ira Jacobs
K. Lea Sewell
Leah Isakov
Sadiq Lula
P2860
P2888
P304
P356
10.1007/S40259-016-0201-6
P407
P577
2016-12-01T00:00:00Z